Results 121 to 130 of about 9,716 (184)

Evidence of histamine release in response to both aerobic and resistance exercise: histamine metabolites as biomarkers. [PDF]

J Appl Physiol (1985)
Gibson BM, Abbotts KSS, Cursetjee HF, Wiedenfeld Needham K, Minson CT, Halliwill JR.   +5 more
europepmc   +1 more source

Irritable Bowel Syndrome Clinical Care Gaps and the Potential of Future Therapeutics Based on Peripheral Visceral Afferent Modulation. [PDF]

Clin Gastroenterol Hepatol
Camilleri M.
europepmc   +1 more source

Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes. [PDF]

Breast Cancer Res Treat
Sirek A, Sirek T, Nowakowski R, Borawski P, Ossowski P, Mitka-Krysiak E, Zmarzły N, Boroń K, Chalcarz M, Kuraszewska B, Szulik M, Boroń D, Grabarek BO.   +12 more
europepmc   +1 more source

Pitolisant disrupts memory consolidation and hippocampal synaptic plasticity: Impaired excitability and long-term potentiation in the CA1 area. [PDF]

Iran J Basic Med Sci
Beheshti S, Badiyifard A, Badiei Darani Z, Azimzadeh M, Halabian A.   +4 more
europepmc   +1 more source

Histamine 2 receptor: Emerging target for the treatment of attention-deficit/hyperactivity disorder. [PDF]

Cell Rep Med
Shan L, Swaab DF.
europepmc   +1 more source

Bacterial Histamine as a Therapeutic Target for Abdominal Pain in Irritable Bowel Syndrome: A Literature Review. [PDF]

Cureus
Mohamed Siraj H, Usaid M, Shaikh S, Dalain M, Ansari Y, Zehra Naqvi S, Hossain R, Anum H, Andrews Ravi C, Pant N, Awasarikar M, Husain K, Anand Hanchate A, Sagam A, Balasubramanian A.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Inhibition of Histamine Release by Histamine controlled by H2 Receptor

Nature, 1973
AGENTS which increase the intracellular level of adenosine 3′-5′-monophosphate (cyclic AMP) in human leukocyte preparations such as the catecholamines, methylxanthines and prostaglandins, inhibit the antigen induced, IgE antibody mediated release of histamine from human leukocytes (basophils)1–3.
L M, Lichtenstein, E, Gillespie
openaire   +2 more sources

Histamine H2-receptor antagonists

Baillière's Clinical Gastroenterology, 1988
The first histamine H2-receptor antagonists were developed in the early 1970s, and they have a dominant role in today's management of peptic ulceration. The original regimens using either cimetidine or ranitidine attempted to control acidity across the 24 hours, but more 'modern' regimens use a large single dose of the H2-blocker in the evening, which ...
openaire   +2 more sources

Histamine H2-Receptor Antagonists

Nursing Clinics of North America, 1991
In summary, histamine initiates acid secretion by stimulating the H2 subtype histamine receptor on parietal cells. Cimetidine, rantidine, famotidine, and nizantidine are histamine H2-receptor antagonists that block this action of histamine, reducing gastric acid output and concentration under both basal and stimulated conditions.
openaire   +2 more sources

Structural elements of H1- and H2-receptors of histamine

General Pharmacology: The Vascular System, 1980
Abstract This article sets out the proposed schemes of histamine H 1 - and H 2 -receptors. These schemes are based on the analysis of histamine agonists activity.
L L, Grechishkin, V L, Goldfarb, L K, Gavrovskaya, N B, Brovtsyna   +3 more
openaire   +2 more sources